-
Forward Look
There Goes the NeighborhoodQ&A with scientist Zena Werb on cancer, immunity and the microenvironment.
by Chris Palmer
-
Forward Look
Cost of Breast Cancer Treatment Affects AdherenceDrug for early-stage cancer must be taken for many years to be effective.
by Kendall K. Morgan
-
From the Editor-in-Chief
The Promise of Precision MedicineThe impact of gene sequencing on the discovery and development of cancer treatments could be profound.
by William G. Nelson, MD, PhD
-
Forward Look
Genetic Testing Can Help Women With Triple-Negative Breast CancerStudy confirms inherited genetic mutations are common, regardless of family history.
by Kendall K. Morgan
-
Forward Look
Medicare to Cover Lung Cancer ScreeningIn high-risk current and former smokers, screening can reduce cancer deaths.
by Michael Eisenstein
-
Forward Look
Does Testicular Cancer Screening Save Lives?Doctors recommend self-exam, even though guidelines discourage it.
by Roxanne Nelson
-
Genomic Testing: The Risk of Knowing Too MuchSophisticated tests can generate a wealth of information about a patient's cancer or disease risk. But they also raise serious questions.
by Alexandra Goho
-
A Dose of PrecisionStereotactic radiation therapy–heavily marketed to consumers–is gaining momentum as a more convenient treatment. But it's not for every patient.
by Sharon Reynolds
-
Healthy Habits
A Cup of Tea?Black tea consumption may be associated with a reduced risk of ovarian cancer.
by Kurt Ullman
-
Q&A
Paying Attention to DepressionPsychiatrist Michael Sharpe suggests a new approach to identifying and treating depression in cancer patients.
by Marci A. Landsmann
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
